Your browser doesn't support javascript.
loading
Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms.
Winter, Susann; Schneider, Marie; Oelschlaegel, Uta; Maggioni, Giulia; Riva, Elena; Raddi, Marco Gabriele; Bencini, Sara; Peruzzi, Benedetta; Choy, Desmond; Antunes Dos Reis, Rita; Güse, Esther; Lischer, Christopher; Vera, Julio; Timms, Jessica A; Sompairac, Nicolas; Sockel, Katja; Poloni, Antonella; Tunger, Antje; Della Porta, Matteo Giovanni; Santini, Valeria; Schmitz, Marc; Platzbecker, Uwe; Kordasti, Shahram.
Afiliação
  • Winter S; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.
  • Schneider M; Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Disease, University of Leipzig Medical Center, Leipzig, Germany.
  • Oelschlaegel U; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.
  • Maggioni G; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Riva E; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Raddi MG; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Bencini S; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
  • Peruzzi B; MDS Unit, Hematology, AOU Careggi - Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
  • Choy D; Flow Cytometry Diagnostic Center and Immunotherapy (CDCI), AOU Careggi, Florence, Italy.
  • Antunes Dos Reis R; Flow Cytometry Diagnostic Center and Immunotherapy (CDCI), AOU Careggi, Florence, Italy.
  • Güse E; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Lischer C; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Vera J; Laboratory of Systems Tumor Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg, and Universitätsklinikum Erlangen, Erlangen, Germany.
  • Timms JA; Deutsches Zentrum Immuntherapie and Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Sompairac N; Laboratory of Systems Tumor Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg, and Universitätsklinikum Erlangen, Erlangen, Germany.
  • Sockel K; Deutsches Zentrum Immuntherapie and Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Poloni A; Laboratory of Systems Tumor Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg, and Universitätsklinikum Erlangen, Erlangen, Germany.
  • Tunger A; Deutsches Zentrum Immuntherapie and Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.
  • Della Porta MG; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Santini V; Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College London, London, UK.
  • Schmitz M; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.
  • Platzbecker U; Department of Clinical and Molecular Sciences, Università Politecnica delle Marche, Ancona, Italy.
  • Kordasti S; Institute of Immunology, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.
Leukemia ; 38(6): 1427-1431, 2024 Jun.
Article em En | MEDLINE | ID: mdl-38632316

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fosfoproteínas / Síndromes Mielodisplásicas / Monócitos / Antígenos HLA-DR / Fatores de Processamento de RNA / Mutação Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fosfoproteínas / Síndromes Mielodisplásicas / Monócitos / Antígenos HLA-DR / Fatores de Processamento de RNA / Mutação Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha